Veru Inc. is a clinical-stage biopharmaceutical company based in Miami, Florida, focused on developing innovative therapeutics for oncology and other significant unmet medical needs. With a robust pipeline of drug candidates, the company is dedicated to addressing various cancers through both novel therapies and improvements to existing treatments. Leveraging proprietary technologies and a strong scientific foundation, Veru aims to advance patient outcomes while enhancing shareholder value by addressing critical healthcare challenges in oncology. Show more

Location: 2916 NORTH MIAMI AVENUE, MIAMI, FL, UNITED STATES, 33127, Miami, FL, 33127, USA | Website: https://verupharma.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

35.95M

52 Wk Range

$2.10 - $7.40

Previous Close

$2.24

Open

$2.24

Volume

63,713

Day Range

$2.21 - $2.37

Enterprise Value

20.59M

Cash

15.79M

Avg Qtr Burn

-5.491M

Insider Ownership

9.78%

Institutional Own.

26.39%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
ENTADFI™ (tadalafil and finasteride) Details Benign prostatic hyperplasia (BPH)	Approved Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Enobosarm +/- abemaciclib Details HER2-expressing cancers, ER+/HER2- breast cancer	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Enobosarm +GLP-1 drugs [Ozempic® + Wegovy® + Mounjaro®] Details Obesity	Phase 2b Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Enobosarm Details Obesity	Phase 2b Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Sabizabulin Details Atherosclerotic cardiovascular disease	IND Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Sabizabulin (Veru-111) Details COVID-19	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Zuclomiphene citrate Details Hot flashes	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
VERU-100 Details Prostate cancer, Cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Sabizabulin (VERU-111) Details Castration-resistant prostate cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Sabizabulin (VERU-111) + Enobosarm Details Triple-negative breast cancer , Cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.